Global Cardiovascular Implants Market 2015-2019

About cardiovascular implants
Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.

Cardiovascular implants are made up of different materials such as metals and its alloys, polymers, and biological materials. There are various cardiovascular implants such as CRTs, ICDs, ICPs, coronary stents, peripheral stents, and heart valves.

Technavio's analysts forecast the global cardiovascular implants market to grow at a CAGR of 4.54% over the period 2014-2019.

Covered in this report
This report covers the present and future scenario of the global cardiovascular implants market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of cardiovascular implants.

Technavio's report, Global Cardiovascular Implants Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

• Americas
• APAC
• EMEA

Key vendors

• Abbott Laboratories
• Boston Scientific
• Medtronic
• St. Jude Medical